The overall gear is to build on the progress we have made and to leverage our recent ground-breaking advances in gene expression profiling technologies.
SPECIFIC AIM 1 : To perform broad, unbiased, deep sequencing of urine from kidney graft recipients undergoing surveillance and/or for-cause biopsies and discover new mRNA and miRNA signatures diagnostic and prognostic of acute rejection (AR), subclinical AR (SAR) and chronic allograft nephropathy (CAN) (SA. IA) and develop novel parameters for characterizing the in-vivo immune status of kidney graft recipients and the adequacy of their immunosuppressive therapy (SA. IB).
SPECIFIC AIM 2 : To test whether a previously discovered 3-gene signature of 18S-normalized CD3? and IP-10 mRNA, measured in sequential urine specimens, predicts the subsequent development of AR and SAR (SA. 2A); to test whether a previously discovered 4-gene signature of vimentin, NKCC2, E-cadherin and 18S rRNA, measured in sequential urine specimens, predicts the subsequent development of CAN (SA. 2B); and to test whether a miRNA panel comprised of miR-21, -21*, -30a-3p, -100; -142-3p/5p, -192, -194, -200b, -222; and -223, measured in sequential urine specimens, predicts the subsequent development of AR, SAR and CAN (SA. 2C).
SPECIFIC AIM 3 : To test whether the previously discovered signatures and the miRNA panel, measured in sequential urine specimens, are associated with the type of induction therapy (T cell depleting antibody induction vs. anti-IL-2 receptor mABs induction) and with maintenance immunosuppressive therapy (tacrolimus vs. no tacrolimus). Messenger RNAs and microRNAs, discovered by sequencing to be associated with AR, SAR and CAN (SA. 1) and measured in sequential samples (SA. 2), will be incorporated in statistical analyses to determine: (1) whether the previously identified signatures can be further optimized to improve their diagnostic and prognostic utility; and (2) whether the previously identified signatures can be further refined to improve their ability to track the influence of induction therapy and maintenance therapy on the immune status of kidney graft recipients.

Public Health Relevance

An excess of immunosuppressive drugs is associated with infections, malignancy and cardiovascular and metabolic aberrations in organ graft recipients whereas inadequate immunosuppression is associated with allograft rejection. Thus, immunosuppression optimization is a major goal in organ transplantation. We propose to develop gene-based prognostic and diagnostic tests for characterizing the in-vivo immune status of kidney graft recipients and for monitoring the adequacy of their immunosuppressive therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI051652-12
Application #
8838698
Study Section
Special Emphasis Panel (NSS)
Program Officer
Hayes, Deborah
Project Start
2002-02-15
Project End
2019-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
12
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Lee, John Richard; Magruder, Matthew; Zhang, Lisa et al. (2018) Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant :
Burnham, Philip; Dadhania, Darshana; Heyang, Michael et al. (2018) Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat Commun 9:2412
Thareja, Gaurav; Yang, Hua; Hayat, Shahina et al. (2018) Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts. Am J Transplant 18:2429-2442
August, Phyllis; Suthanthiran, Manikkam (2017) Sex and Kidney Transplantation: Why Can't a Woman Be More Like a Man? J Am Soc Nephrol 28:2829-2831
Suhre, Karsten; Schwartz, Joseph E; Sharma, Vijay K et al. (2016) Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. J Am Soc Nephrol 27:626-36
Lee, John R; Muthukumar, Thangamani; Dadhania, Darshana et al. (2015) Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One 10:e0122399
Kannabhiran, Dinesh; Lee, John; Schwartz, Joseph E et al. (2015) Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation 99:1156-64
Matignon, Marie; Ding, Ruchuang; Dadhania, Darshana M et al. (2014) Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol 25:1586-97
Lee, John R; Muthukumar, Thangamani; Dadhania, Darshana et al. (2014) Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev 258:218-40
Lee, John R; Dadhania, Darshana; August, Phyllis et al. (2014) Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients. Transplantation 98:292-9

Showing the most recent 10 out of 25 publications